Clinical Trial Update: Conmana Combined With Thalidomide to Treat NSCLC [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating Conmana in combination with thalidomide for non-small cell lung cancer, with the current status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Conmana
• Thalidomide (thalidomide)

Snippet

Sponsor: Henan Provincial People's Hospital | Conditions: NSCLC | Phase 4 | Status: UNKNOWN